Update on long-term outcomes of a cohort of patients with -positive acute lymphoblastic leukemia treated with blinatumomab and stem cell transplantation
Aida Zečkanović(University Children's Hospital Zurich), Jean-Pierre Bourquin, Draga Barbaric(UNSW Sydney), Julia Alten(Christian-Albrechts-Universität zu Kiel), Volkan Hazar, Emmanuelle Clappier(Centre National de la Recherche Scientifique), Yöntem Yaman, Luciana Vinti(Bambino Gesù Children's Hospital), Gunnar Cario, Joachim B. Kunz(Heidelberg University), Jochen Buechner(Oslo University Hospital), Magnus Aasved Hjort(St Olav's University Hospital), Loïc Vasseur(Assistance Publique – Hôpitaux de Paris), Nicole Bodmer(University Children's Hospital Zurich), Brice Mouttet(University Children's Hospital Zurich), Laure Farnault(Aix-Marseille Université), Sema Anak, David O’Connor(Great Ormond Street Hospital), B Brethon, Nicolas Boissel(Inserm), Philip Ancliff(Great Ormond Street Hospital), Sarah Elitzur(Tel Aviv University), A Möricke, Jerry Stein, Katharine Patrick(Sheffield Children's NHS Foundation Trust), Martin Schrappe, Sarah Bonnet, et al., Franco Locatelli, Gabriele Escherich, Jack Bartram(Great Ormond Street Hospital), André Baruchel, Angus Hodder(Great Ormond Street Hospital for Children NHS Foundation Trust)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
|The Lancet|2021|795
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577